Rosen, Jurij
Werner, Jan-Michael
Ceccon, Garry S.
Rosen, Elena K.
Wollring, Michael M.
Stetter, Isabelle
Lohmann, Philipp
Mottaghy, Felix M.
Marner, Lisbeth
Law, Ian
Fink, Gereon R.
Langen, Karl-Josef
Galldiks, Norbert https://orcid.org/0000-0002-2485-1796
Funding for this research was provided by:
Universitätsklinikum Köln
Article History
Received: 20 February 2025
Accepted: 20 May 2025
First Online: 4 June 2025
Declarations
:
: The input data of the present study were derived from the results of previously published studies by Marner et al. [] and Dunkl et al. []. These studies had been performed in line with the principles of the Declaration of Helsinki and the respective institutional review board had approved these studies (Marner et al., file number: H-6–2014-095; Dunkl et al., file number: EK 022/14).
: Informed consent had been obtained from the legal guardians of the minor study participants included in the study.
: The legal guardians of the minor study participants had given written informed consent for assessment of clinical data for scientific purposes and subsequent publication.
: NG received honoraria for lectures from Blue Earth Diagnostics, for advisory board participation from Telix Pharmaceuticals and Servier, and for consultancy services from Telix Pharmaceuticals. PL received honoraria for lectures from Blue Earth Diagnostics. KL received honoraria from Telix Pharmaceuticals for consultancy services. FMM is an Editor of the European Journal of Nuclear Medicine and Molecular Imaging. The other authors disclosed no potential conflicts of interest related to the present work.